Literature DB >> 24890348

Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

Salma K Jabbour1, Sameh A Hashem2, Walter Bosch3, Tae Kyoung Kim4, Steven E Finkelstein5, Bethany M Anderson6, Edgar Ben-Josef7, Christopher H Crane8, Karyn A Goodman9, Michael G Haddock10, Joseph M Herman11, Theodore S Hong12, Lisa A Kachnic13, Harvey J Mamon14, Jason R Pantarotto15, Laura A Dawson16.   

Abstract

PURPOSE: To standardize upper abdominal normal organ contouring guidelines for Radiation Therapy Oncology Group (RTOG) trials. METHODS AND MATERIALS: Twelve expert radiation oncologists contoured the liver, esophagus, gastroesophageal junction (GEJ), stomach, duodenum, and common bile duct (CBD), and reviewed and edited 33 additional normal organ and blood vessel contours on an anonymized patient computed tomography (CT) dataset. Contours were overlaid and compared for agreement using MATLAB (MathWorks, Natick, MA). S95 contours, defined as the binomial distribution to generate 95% group consensus contours, and normal organ contouring definitions were generated and reviewed by the panel.
RESULTS: There was excellent consistency and agreement of the liver, duodenal, and stomach contours, with substantial consistency for the esophagus contour, and moderate consistency for the GEJ and CBD contours using a Kappa statistic. Consensus definitions, detailed normal organ contouring recommendations and high-resolution images were developed.
CONCLUSIONS: Consensus contouring guidelines and a CT image atlas should improve contouring uniformity in radiation oncology clinical planning and RTOG trials.
Copyright © 2014 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24890348      PMCID: PMC4285338          DOI: 10.1016/j.prro.2013.06.004

Source DB:  PubMed          Journal:  Pract Radiat Oncol        ISSN: 1879-8500


  13 in total

1.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

2.  The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333-39.

Authors:  Yeung Yuk Pang
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

3.  A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.

Authors:  James D Murphy; Claudia Christman-Skieller; Jeff Kim; Sonja Dieterich; Daniel T Chang; Albert C Koong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-14       Impact factor: 7.038

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  Anatomy of the portal vein bifurcation: intra- versus extrahepatic location--implications for transjugular intrahepatic portosystemic shunts.

Authors:  S R Schultz; J M LaBerge; R L Gordon; R S Warren
Journal:  J Vasc Interv Radiol       Date:  1994 May-Jun       Impact factor: 3.464

6.  A survey of stereotactic body radiotherapy use in the United States.

Authors:  Hubert Pan; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson
Journal:  Cancer       Date:  2011-03-15       Impact factor: 6.860

7.  Tools for consensus analysis of experts' contours for radiotherapy structure definitions.

Authors:  Rawan Allozi; X Allen Li; Julia White; Aditya Apte; An Tai; Jeff M Michalski; Walter R Bosch; Issam El Naqa
Journal:  Radiother Oncol       Date:  2010-08-11       Impact factor: 6.280

8.  Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

Authors:  Feng-Ming Spring Kong; Timothy Ritter; Douglas J Quint; Suresh Senan; Laurie E Gaspar; Ritsuko U Komaki; Coen W Hurkmans; Robert Timmerman; Andrea Bezjak; Jeffrey D Bradley; Benjamin Movsas; Lon Marsh; Paul Okunieff; Hak Choy; Walter J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

9.  Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.

Authors:  Hiram A Gay; H Joseph Barthold; Elizabeth O'Meara; Walter R Bosch; Issam El Naqa; Rawan Al-Lozi; Seth A Rosenthal; Colleen Lawton; W Robert Lee; Howard Sandler; Anthony Zietman; Robert Myerson; Laura A Dawson; Christopher Willett; Lisa A Kachnic; Anuja Jhingran; Lorraine Portelance; Janice Ryu; William Small; David Gaffney; Akila N Viswanathan; Jeff M Michalski
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-06       Impact factor: 7.038

10.  Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma.

Authors:  Jiayi Huang; John M Robertson; Hong Ye; Jeffrey Margolis; Laura Nadeau; Di Yan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-16       Impact factor: 7.038

View more
  25 in total

Review 1.  Simple diagrammatic approach to delineate duodenum on a radiotherapy planning CT scan.

Authors:  Tejinder Kataria; Deepak Gupta; Trinanjan Basu; Shivani Gupta; Shikha Goyal; Susovan Banerjee; Ashu Abhishek; Shyam S Bisht; Kushal Narang
Journal:  Br J Radiol       Date:  2015-12-09       Impact factor: 3.039

2.  Dosimetric parameters correlate with duodenal histopathologic damage after stereotactic body radiotherapy for pancreatic cancer: Secondary analysis of a prospective clinical trial.

Authors:  Vivek Verma; Audrey J Lazenby; Dandan Zheng; Abhijeet R Bhirud; Quan P Ly; Chandrakanth Are; Aaron R Sasson; Chi Lin
Journal:  Radiother Oncol       Date:  2017-01-12       Impact factor: 6.280

3.  Evaluating inter-campus plan consistency using a knowledge based planning model.

Authors:  Sean L Berry; Rongtao Ma; Amanda Boczkowski; Andrew Jackson; Pengpeng Zhang; Margie Hunt
Journal:  Radiother Oncol       Date:  2016-07-06       Impact factor: 6.280

4.  Influence of position and radiation technique on organs at risk in radiotherapy of rectal cancer.

Authors:  Jun-Feng Wang; Hui Li; Hua Xiong; He Huang; Yan-Mei Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

5.  Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma.

Authors:  He Wang; Sarah A Milgrom; Bouthaina S Dabaja; Grace L Smith; Mary Martel; Chelsea C Pinnix
Journal:  Pract Radiat Oncol       Date:  2017-03-06

6.  General and custom deep learning autosegmentation models for organs in head and neck, abdomen, and male pelvis.

Authors:  Asma Amjad; Jiaofeng Xu; Dan Thill; Colleen Lawton; William Hall; Musaddiq J Awan; Monica Shukla; Beth A Erickson; X Allen Li
Journal:  Med Phys       Date:  2022-02-07       Impact factor: 4.071

7.  Dose Prediction Model for Duodenum Sparing With a Biodegradable Hydrogel Spacer for Pancreatic Cancer Radiation Therapy.

Authors:  Ziwei Feng; Avani D Rao; Zhi Cheng; Eun Ji Shin; Joseph Moore; Lin Su; Seong-Hun Kim; John Wong; Amol Narang; Joseph M Herman; Todd McNutt; Dengwang Li; Kai Ding
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-07-19       Impact factor: 7.038

8.  Intensity modulated radiation therapy with simultaneous integrated boost based dose escalation on neoadjuvant chemoradiation therapy for locally advanced distal esophageal adenocarcinoma.

Authors:  Ming Zeng; Fernando N Aguila; Taral Patel; Mark Knapp; Xue-Qiang Zhu; Xi-Lin Chen; Phillip D Price
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

9.  Individualized 4-dimensional computed tomography proton treatment for pancreatic tumors.

Authors:  Matthew L Knecht; Ning Wang; April Vassantachart; Rachel Mifflin; Jerry D Slater; Gary Y Yang
Journal:  J Gastrointest Oncol       Date:  2017-08

10.  Neural network dose models for knowledge-based planning in pancreatic SBRT.

Authors:  Warren G Campbell; Moyed Miften; Lindsey Olsen; Priscilla Stumpf; Tracey Schefter; Karyn A Goodman; Bernard L Jones
Journal:  Med Phys       Date:  2017-11-01       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.